Literature DB >> 24935819

Exploring genetic variants predisposing to diabetes mellitus and their association with indicators of socioeconomic status.

Börge Schmidt1, Nico Dragano, André Scherag, Sonali Pechlivanis, Per Hoffmann, Markus M Nöthen, Raimund Erbel, Karl-Heinz Jöckel, Susanne Moebus.   

Abstract

BACKGROUND: The relevance of disease-related genetic variants for the explanation of social inequalities in complex diseases is unclear and empirical analyses are largely missing. The aim of our study was to examine whether genetic variants predisposing to diabetes mellitus are associated with socioeconomic status in a population-based cohort.
METHODS: We genotyped 11 selected diabetes-related single nucleotide polymorphisms in 4655 participants (age 45-75 years) of the Heinz Nixdorf Recall study. Diabetes status was self-reported or defined by blood glucose levels. Education, income and paternal occupation were assessed as indicators of socioeconomic status. Multiple regression analyses were used to examine the association of socioeconomic status and diabetes by estimating sex-specific and age-adjusted prevalence ratios and their corresponding 95%-confidence intervals. To explore the relationship between individual single nucleotide polymorphisms and socioeconomic status sex- and age-adjusted odds ratios were computed. We adjusted the alpha-level for multiple testing of 11 single nucleotide polymorphisms using Bonferroni's method (α(BF) ~ 0.005). In addition, we explored the association of a genetic risk score with socioeconomic status.
RESULTS: Social inequalities in diabetes were observed for all indicators of socioeconomic status. However, there were no significant associations between individual diabetes-related risk alleles and socioeconomic status with odds ratios ranging from 0.87 to 1.23. Similarly, the genetic risk score analysis revealed no evidence for an association.
CONCLUSIONS: Our data provide no evidence for an association between 11 diabetes-related risk alleles and different indicators of socioeconomic status in a population-based cohort, suggesting that the explored genetic variants do not contribute to health inequalities in diabetes.

Entities:  

Mesh:

Year:  2014        PMID: 24935819      PMCID: PMC4071333          DOI: 10.1186/1471-2458-14-609

Source DB:  PubMed          Journal:  BMC Public Health        ISSN: 1471-2458            Impact factor:   3.295


Background

Indicators of socioeconomic status (SES) are strongly related to health conditions with groups of low SES showing higher prevalence and incidence for almost all diseases [1-3]. Despite the evidence that differences in working and living conditions, health behaviors and psychosocial factors are important determinants underlying these health inequalities [4-6], twin and other types of family studies suggest a contribution of genetic factors due to selection effects [7-9]. However, on the molecular level the relevance of disease-related genetic variants for the explanation of social inequalities in health is still unclear and theoretical approaches as well as empirical analyses incorporating genetic data are largely missing. Learning more about the possible role of genetic factors in health inequalities is considered to further improve the understanding of population health in general and of health inequalities in particular. If differences in genetic predisposition of a certain disease had an impact on health inequalities, it would be expected that the disease itself would have an influence on SES through intra- and intergenerational processes of social mobility, allowing for a higher frequency of disease-related risk alleles in lower SES groups [10]. This assumption is described by the hypothesis of direct health selection supposing that individuals with good health are more likely to move upward in SES than individuals with poor health and vice versa [11]. Incorporating genetic factors in the hypothesis of direct health selection would give disease-related risk alleles an impact on SES through a mediating effect of disease. However, direct health selection cannot be regarded as the main explanation for health inequalities because processes of social mobility are scarce in older ages when most diseases arise [11,12]. Particularly, if focusing on late onset diseases and measures of SES representing early life conditions or conditions across the life span (e.g., parental SES, education), reverse causation is unlikely. With regard to common complex diseases it is supposed that next to environmental factors a large number of genetic variants contribute to disease etiology. In the recent past, disease-related risk alleles were primarily identified by genomewide-association studies (GWAS) following the common disease – common variants hypothesis [13]. These GWAS-based gene variants usually have small to modest individual effects [14], however strong relationships between common variants and complex traits would be necessary to gain a further prerequisite for supposed differences in allele frequencies between SES groups [15]. Hence, there is little reason to assume that differences in genetic predisposition to complex diseases play a role in health inequalities. To reconsider this argument by empirical analysis on the molecular level, the aim of this study was to examine whether there are associations between different SES indicators and genetic variants predisposing to diabetes mellitus as an example for a late onset complex disease. The inverse relationship between indicators of SES and diabetes is well reported across different populations [1,16-18]. In addition, a large number of genomic loci robustly associated with diabetes were identified through GWAS in the recent past [19-21]. To date, no studies have examined the association of SES and diabetes-related genetic variants to explore whether SES differences in genetic predisposition contribute to health inequalities in diabetes.

Methods

Study population

Data was used from the baseline examination of the Heinz Nixdorf Recall (Risk Factors, Evaluation of Coronary Calcium, and Lifestyle) Study, a prospective population-based cohort study. The rationale and design of the study were described elsewhere [22]. A random sample derived from mandatory citizen registries of three large cities (Bochum, Essen, Mülheim/Ruhr) in an urban region in the western part of Germany was used to recruit 4814 women and men aged 45–75 years. Baseline examination took place from 2000 to 2003 and the baseline response proportion was 55.8% [23]. Written informed consent was obtained from all participants. The study was approved by the institutional ethics committee of the University Hospital Essen and comprises extended quality management procedures, including a certification according to DIN ISO 9001:2000.

Data assessment

Diabetes was defined as either of the following criteria: reported history of diabetes, taking glucose-lowering drugs, having fasting blood glucose levels of greater than 125 mg/dL, or having nonfasting glucose levels of 200 mg/dL or greater. Overall, 23 participants reported early disease onset indicating rather Type 1 than Type 2 diabetes. In analyses excluding these 23 participants virtually identical results were obtained as those presented in the following. To be consistent with a previous study using the same data [24] we decided to include the 23 participants in the analyses. Based on literature research the following 11 single nucleotide polymorphisms (SNPs) related to 8 genetic loci (in parentheses) derived from GWAS for diabetes in European-origin populations were selected: rs4402960 (insulin-like growth factor-binding protein 2 [IGF2BP2]), rs1801282 (peroxisome proliferator-activated receptor gamma [PPARG]), rs7754840, rs7756992, rs10946398 (CDK5 regulatory subunit associated protein 1-like 1 [CDKAL1]), rs13266634 (solute carrier family 30 (zinc transporter), member 8 [SLC30A8]), rs10811661, rs564398 (cyclin-dependent kinase inhibitor 2A/2B [CDKN2A/2B]), rs7903146 (transcription factor 7-like2 [TCF7L27]), rs1111875 (hematopoietically-expressed homeobox [HHEX]) and rs8050136 (fat mass and obesity associated [FTO]). These SNPs include common variants with some of the highest effects on diabetes risk reported to date [19-21]. The literature research took place in January 2009 and was previously described in detail [24]. Genotyping was performed by matrix-assisted laser desorption ionization-time of flight mass spectrometry-based iPLEX Gold assay at the Department of Genomics, Life and Brain Center, Bonn, Germany. Education, income and paternal occupation were collected as SES indicators by standardized interviews. Paternal occupation was classified referring to the International Standard Classification of Occupations (ISCO-88) [25] and categorized into four groups (unskilled employees/workers; qualified (skilled) employees/workers; technicians and associate professionals; managers and professionals). Education was defined by combining school and vocational training as total years of formal education according to the International Standard Classification of Education [26] and categorized into three groups with the lowest educational group of 10 and less years (equivalent to a basic school degree with no vocational training), the medium educational group of 11 to 13 years (equivalent to upper secondary educational degrees or a combination of lower secondary education and vocational training) and the highest educational group of 14 and more years of education (equivalent to a vocational training including additional qualification or a university degree). In previous analyses of the same study population no further differentiation between university degrees and other types of higher education has been made because of the small number of diabetes cases in the respective group. This small sample size would have caused problems in conducting multivariate analyses. Income was measured as the monthly household equivalent income calculated by dividing the total household net income by a weighting factor for each household member [27]. Income was included into analyses either as a continuous variable or divided into four groups using sex-specific quartiles.

Statistical analyses

The analyses were conducted with 4655 participants who had information on diabetes status, indicators of SES and genetic data. Some observations on paternal occupation (n = 258), education (n = 14) and income (n = 296) were missing. As the SES indicators were analyzed separately, these participants were excluded only from the respective analyses. No correlations between missing SES measures and diabetes status were observed. All analyses were performed using the R statistical package version 2.14.0 [28] and PLINK (v1.07) for Windows [29]. First, log-binomial regression models were fitted to assess the association of SES indicators and diabetes status by estimating sex-specific and age-adjusted prevalence ratios (PR) and their corresponding 95%-confidence intervals (95%-CIs). Education, income and paternal occupation were entered separately as categorical predictors by coding dummy variables with the highest category as reference. Second, logistic regression models were fitted to check the association of the GWAS-based SNP alleles to diabetes status. Therefore, sex- and age-adjusted odds ratios (OR) and 95%-CIs were estimated under a (log-)additive genetic model for each SNP, as suggested in previous studies [19,20]. In addition, a genetic risk score was developed by adding the risk alleles (0/1/2) of the diabetes-related SNPs for each participant to explore the association between the sum of risk alleles and diabetes status. For missing genotype information expected values were imputed based on the risk allele frequency of the respective SNP in the study population. SNP pruning for the genetic risk score was performed using pairwise linkage disequilibrium of r  > 0.8 as cut off to account for correlated effects, resulting in the exclusion of rs1094639. The calculated effect size estimators are to be interpreted as average effects for one additional risk allele. Third, for the primary research question the relationship between each SNP and SES was explored by computing sex- and age-adjusted ORs and 95%-CIs under a (log-)additive, dominant and recessive genetic model. Again, categorical education, income and paternal occupation were used separately as indicators of SES. For each SES category a binary outcome variable with the highest category as reference was entered in a logistic regression model. Income was also used as a continuous variable in a linear regression model to estimate standardized effect sizes and 95%-CI for each SNP. For this analysis income was loge-transformed to normalize the distribution. According to our knowledge, no association of the selected SNPs to SES has been demonstrated previously. Hence, it was decided to control the family-wise error rate of the primary research question at α = 0.05. We adjusted the alpha-level for multiple testing of 11 SNPs using Bonferroni’s method (αBF ~ 0.005). In addition, the association between the genetic risk score and SES was explored using the SES indicators as outcome.

Results

Characteristics of the study population are shown in Table 1. Of the 4655 participants 13.6% (n = 634) had diabetes with women having a lower prevalence (9.8%) than men (17.4%). Differences between women and men in the distribution of two SES indicators were observed: Women reported less years of formal education and showed a lower median income.Inequalities in all SES indicators were related to diabetes status for both women and men (Figures 1, 2 and 3). The comparison of men in the lowest category of paternal occupation (unskilled employees/workers) to those in the highest category (managers and professionals) showed an age-adjusted PR of 1.5 (95%-CI: 1.0-2.3) for the occurrence of diabetes in the study population. The respective PR for women was 1.6 (95%-CI: 0.9-3.0). The analyses for education (≤10 years of education vs. ≥ 14 years; women: PR 2.3, 95%-CI: 1.4-3.9; men: PR 1.4, 95%-CI: 1.0-2.0) and income (lowest sex-specific quartile vs. highest sex-specific quartile; women: PR 2.0, 95%-CI: 1.3-3.2; men: PR 1.2, 95%-CI: 0.9-1.5) showed similar results. There are gender differences with women revealing stronger associations with diabetes status across all SES indicators.
Table 1

Characteristics of the study population

 FemaleMale
N
2322
2333
Age (years)a
59.6 +/- 7.8
59.6 +/- 7.8
45-54b
725 (31.2%)
726 (31.1%)
55-64b
916 (39.4%)
917 (39.3%)
65-74b
681 (29.3%)
690 (29.6%)
Diabetes mellitusb
227 (9.8%)
407 (17.4%)
Paternal occupationb
 
 
Unskilled employees/workers
270 (12.4%)
229 (10.3%)
Qualified (skilled) employees/workers
1283 (59.1%)
1363 (61.2%)
Technicians and associate professionals
392 (18.1%)
398 (17.9%)
Managers and professionals
226 (10.4%)
236 (10.6%)
Education (years of training)b
 
 
≤10
411 (17.7%)
119 (5.1%)
11–13
1465 (63.2%)
1110 (47.8%)
≥14
443 (19.1%)
1093 (47.1%)
Income (EURO/month)c
1313 (937-1875)
1520 (1108-2073)
Log e (income)a7.19 +/- 0.497.32 +/- 0.46

amean (+/- standard deviation).

bnumber (%).

cmedian (interquartile range).

Figure 1

Paternal occupation and diabetes: age-adjusted prevalence ratios and 95% confidence intervals for the association of paternal occupation and diabetes for women (white) and men (black) (by groups; ‘managers and professionals’ as reference).

Figure 2

Education and diabetes: age-adjusted prevalence ratios and 95% confidence intervals for the association of education and diabetes for women (white) and men (black) (by groups; ‘> = 14 years of education’ as reference).

Figure 3

Income and diabetes: age-adjusted prevalence ratios and 95% confidence intervals for the association of income and diabetes for women (white) and men (black) (by sex-specific quartiles; highest quartile as reference).

Characteristics of the study population amean (+/- standard deviation). bnumber (%). cmedian (interquartile range). Paternal occupation and diabetes: age-adjusted prevalence ratios and 95% confidence intervals for the association of paternal occupation and diabetes for women (white) and men (black) (by groups; ‘managers and professionals’ as reference). Education and diabetes: age-adjusted prevalence ratios and 95% confidence intervals for the association of education and diabetes for women (white) and men (black) (by groups; ‘> = 14 years of education’ as reference). Income and diabetes: age-adjusted prevalence ratios and 95% confidence intervals for the association of income and diabetes for women (white) and men (black) (by sex-specific quartiles; highest quartile as reference). Table 2 shows the estimated ORs of the logistic regression models for the 11 selected SNPs and diabetes status. All effect size estimators are small to modest with ORs ranging from 1.01 to 1.28 for each risk allele. The SNPs rs4402960 (IGF2BP2), rs7756992 (CDKAL1), rs13266634 (SLC30A8), rs1111875 (HHEX), and rs7903146 (TCF7L2) showed statistically significant associations at a nominal α level of 0.05. For the genetic risk score a clear association with diabetes status could be observed (OR: 1.12, 95%-CI: 1.07-1.16, p: 5.95 × 10-8).
Table 2

Genetic association analyses for diabetes: odds ratios, 95% confidence intervals and p-values for the genetic association analyses for diabetes using SNPs (additive genetic model), sex and age in a logistic regression model (CHR, chromosome)

CHRGeneSNPPhysical positionSupposed risk alleleFrequency in cohortOR(95% CI) p
3
PPARG
rs1801282
12393125
C
0.86
1.11
(0.92–1.33)
0.27
3
IGF2BP2
rs4402960
185511687
T
0.31
1.27
(1.12–1.44)
3.05 × 10-4
6
CDKAL1
rs10946398
20661034
C
0.33
1.07
(0.94–1.22)
0.28
6
CDKAL1
rs7754840
20661250
C
0.33
1.06
(0.93–1.20)
0.41
6
CDKAL1
rs7756992
20679709
G
0.29
1.16
(1.01–1.33)
0.04
8
SLC30A8
rs13266634
118184783
C
0.69
1.16
(1.01–1.32)
0.04
9
CDKN2A/2B
rs564398
22029547
A
0.58
1.09
(0.96–1.23)
0.21
9
CDKN2A/2B
rs10811661
22134094
T
0.83
1.01
(0.85–1.19)
0.96
10
HHEX
rs1111875
94462882
G
0.60
1.14
(1.01–1.29)
0.04
10
TCF7L2
rs7903146
114758349
T
0.27
1.28
(1.13–1.46)
1.67 × 10-4
16FTOrs805013653816275A0.411.08(0.95–1.22)0.23
Genetic association analyses for diabetes: odds ratios, 95% confidence intervals and p-values for the genetic association analyses for diabetes using SNPs (additive genetic model), sex and age in a logistic regression model (CHR, chromosome) The results for the logistic regression models for the 11 SNPs and paternal occupation under a (log-)additive genetic model are shown in Table 3. No statistically significant associations at αBF ~ 0.005 were observed. The estimated ORs were small to modest ranging from 0.87 to 1.23 for each respective diabetes risk allele. The logistic regression models for the outcomes education (Table 4) and income (Table 5) revealed similar results with no statistically significant associations at αBF ~ 0.005 and ORs ranging from 0.88 to 1.16 (education) and 0.87 to 1.14 (income). Under a dominant and recessive genetic model no deviant results to those under a (log-)additive model were obtained (results not shown). Furthermore, no statistically significant associations were observed for the analysis using loge-transformed income (results not shown). This was consistent with the observation for income as a categorized outcome.
Table 3

Genetic association analyses for paternal occupation: odds ratios, 95% confidence intervals and p-values for the genetic association analyses for paternal occupation (by groups; ‘managers and professionals’ as reference) using SNPs (additive genetic model), sex and age in a logistic regression model (CHR, chromosome)

 
 
 
 
 
Unskilled employees/workers
Qualified employees/workers
Technicians/associate pros.
CHRGeneSNPPhysical positionSupposed risk alleleOR(95% CI) p OR(95% CI) p OR(95% CI) p
3
PPARG
rs1801282
12393125
C
1.00
(0.77–1.30)
1.00
0.95
(0.77–1.17)
0.62
0.96
(0.76–1.22)
0.75
3
IGF2BP2
rs4402960
185511687
T
1.04
(0.86–1.26)
0.67
1.02
(0.87–1.18)
0.85
0.99
(0.83–1.18)
0.95
6
CDKAL1
rs10946398
20661034
C
1.01
(0.83–1.23)
0.94
1.15
(0.99–1.34)
0.08
1.17
(0.98–1.39)
0.09
6
CDKAL1
rs7754840
20661250
C
0.99
(0.82–1.21)
0.94
1.13
(0.97–1.32)
0.12
1.16
(0.97–1.39)
0.10
6
CDKAL1
rs7756992
20679709
G
1.06
(0.86–1.30)
0.59
1.13
(0.96–1.33)
0.15
1.23
(1.02–1.49)
0.03
8
SLC30A8
rs13266634
118184783
C
1.07
(0.88–1.31)
0.47
1.09
(0.94–1.26)
0.27
1.21
(1.01–1.46)
0.04
9
CDKN2A/2B
rs564398
22029547
A
0.95
(0.79–1.15)
0.63
0.94
(0.81–1.09)
0.39
0.94
(0.79–1.11)
0.46
9
CDKN2A/2B
rs10811661
22134094
T
0.98
(0.77–1.24)
0.85
1.10
(0.91–1.33)
0.33
0.94
(0.76–1.17)
0.59
10
HHEX
rs1111875
94462882
G
0.87
(0.72–1.05)
0.14
0.97
(0.84–1.12)
0.71
0.98
(0.83–1.16)
0.80
10
TCF7L2
rs7903146
114758349
T
0.89
(0.73–1.09)
0.26
0.92
(0.78–1.07)
0.28
1.01
(0.84–1.20)
0.95
16FTOrs805013653816275A1.09(0.90–1.31)0.381.05(0.91–1.21)0.531.00(0.85–1.18)1.00
Table 4

Genetic association analyses for education: odds ratios, 95% confidence intervals and p-values for the genetic association analyses for education (by groups; ‘> = 14 years of education’ as reference) using SNPs (additive genetic model), sex and age in a logistic regression model (CHR, chromosome)

 
 
 
 
 
<=10 years
11-13 years
CHRGeneSNPPhysical positionSupposed risk alleleOR(95% CI) p OR(95% CI) p
3
PPARG
rs1801282
12393125
C
1.05
(0.82–1.34)
0.72
1.02
(0.89–1.17)
0.76
3
IGF2BP2
rs4402960
185511687
T
0.95
(0.80–1.13)
0.58
0.88
(0.80–0.98)
0.02
6
CDKAL1
rs10946398
20661034
C
1.08
(0.91–1.29)
0.37
1.01
(0.91–1.11)
0.89
6
CDKAL1
rs7754840
20661250
C
1.06
(0.89–1.27)
0.48
1.00
(0.91–1.11)
0.95
6
CDKAL1
rs7756992
20679709
G
1.07
(0.89–1.29)
0.45
1.00
(0.90–1.11)
0.95
8
SLC30A8
rs13266634
118184783
C
1.06
(0.89–1.27)
0.50
0.91
(0.82–1.01)
0.06
9
CDKN2A/2B
rs564398
22029547
A
1.04
(0.88–1.23)
0.66
1.00
(0.91–1.10)
0.99
9
CDKN2A/2B
rs10811661
22134094
T
1.16
(0.92–1.46)
0.21
1.13
(0.99–1.28)
0.07
10
HHEX
rs1111875
94462882
G
0.92
(0.78–1.08)
0.31
0.97
(0.88–1.07)
0.51
10
TCF7L2
rs7903146
114758349
T
1.04
(0.87–1.25)
0.64
0.98
(0.88–1.09)
0.71
16FTOrs805013653816275A0.96(0.82–1.14)0.650.95(0.86–1.05)0.30
Table 5

Genetic association analyses for income: odds ratios, 95% confidence intervals and p-values for the genetic association analyses for income (by sex-specific quartiles; highest quartile as reference) using SNPs (additive genetic model) and age in a logistic regression model (CHR, chromosome)

 
 
 
 
 
Lowest quartile
2nd quartile
3rd quartile
CHRGeneSNPPhysical positionSupposed risk alleleOR(95% CI) p OR(95% CI) p OR(95% CI) p
3
PPARG
rs1801282
12393125
C
1.14
(0.95–1.38)
0.15
0.98
(0.82–1.17)
0.82
1.02
(0.86–1.22)
0.80
3
IGF2BP2
rs4402960
185511687
T
1.00
(0.87–1.14)
0.97
0.96
(0.84–1.10)
0.59
0.96
(0.84–1.09)
0.50
6
CDKAL1
rs10946398
20661034
C
0.96
(0.84–1.09)
0.51
0.91
(0.80–1.04)
0.17
0.91
(0.80–1.03)
0.13
6
CDKAL1
rs7754840
20661250
C
0.96
(0.85–1.10)
0.59
0.92
(0.81–1.06)
0.24
0.90
(0.79–1.03)
0.11
6
CDKAL1
rs7756992
20679709
G
0.99
(0.86–1.14)
0.87
0.92
(0.80–1.06)
0.26
0.87
(0.75–1.00)
0.04
8
SLC30A8
rs13266634
118184783
C
0.99
(0.87–1.13)
0.88
0.98
(0.85–1.12)
0.75
0.98
(0.86–1.12)
0.73
9
CDKN2A/2B
rs564398
22029547
A
0.99
(0.87–1.13)
0.87
1.02
(0.90–1.17)
0.73
1.01
(0.89–1.15)
0.86
9
CDKN2A/2B
rs10811661
22134094
T
1.04
(0.88–1.24)
0.65
0.99
(0.83–1.17)
0.87
0.90
(0.76–1.06)
0.20
10
HHEX
rs1111875
94462882
G
0.94
(0.83–1.07)
0.35
0.86
(0.76–0.98)
0.02
0.94
(0.83–1.07)
0.35
10
TCF7L2
rs7903146
114758349
T
0.94
(0.81–1.07)
0.34
0.95
(0.83–1.09)
0.47
0.92
(0.80–1.05)
0.22
16FTOrs805013653816275A0.95(0.84–1.08)0.450.98(0.87–1.11)0.740.92(0.82–1.05)0.21
Genetic association analyses for paternal occupation: odds ratios, 95% confidence intervals and p-values for the genetic association analyses for paternal occupation (by groups; ‘managers and professionals’ as reference) using SNPs (additive genetic model), sex and age in a logistic regression model (CHR, chromosome) Genetic association analyses for education: odds ratios, 95% confidence intervals and p-values for the genetic association analyses for education (by groups; ‘> = 14 years of education’ as reference) using SNPs (additive genetic model), sex and age in a logistic regression model (CHR, chromosome) Genetic association analyses for income: odds ratios, 95% confidence intervals and p-values for the genetic association analyses for income (by sex-specific quartiles; highest quartile as reference) using SNPs (additive genetic model) and age in a logistic regression model (CHR, chromosome) Table 6 shows the results using the genetic risk score in logistic regression models for all SES indicators. The estimated ORs are close to 1.0 and statistically significant results at a nominal α level of 0.05 were observed only for income comparing the 3rd quartile with the highest quartile (OR 0.95, 95%-CI: 0.91-0.99).
Table 6

Genetic association analyses using a genetic risk score: odds ratios, 95% confidence intervals and p-values for the genetic association analyses for paternal occupation and education (both by groups; highest group as reference) using SNPs (genetic risk score), sex and age in a logistic regression model as well as for income (by sex-specific quartiles; highest quartile as reference) using SNPs (genetic risk score) and age in a logistic regression model

 OR(95% CI) p OR(95% CI) p OR(95% CI) p
Paternal occupation
unskilled employees/workers
qualified employees/workers
technicians/associate pros.
 
0.99
(0.94–1.05)
0.82
1.02
(0.98–1.07)
0.36
1.03
(0.98–1.09)
0.24
Education
<=10 years
11-13 years
 
 
 
 
1.02
(0.96–1.07)
0.52
0.98
(0.95–1.01)
0.15
 
 
 
Income
lowest quartile
2nd quartile
3rd quartile
 0.99(0.95–1.03)0.470.96(0.92–1.00)0.050.95(0.91–0.99)0.01
Genetic association analyses using a genetic risk score: odds ratios, 95% confidence intervals and p-values for the genetic association analyses for paternal occupation and education (both by groups; highest group as reference) using SNPs (genetic risk score), sex and age in a logistic regression model as well as for income (by sex-specific quartiles; highest quartile as reference) using SNPs (genetic risk score) and age in a logistic regression model

Discussion

The presented data showed an association between all indicators of SES and diabetes status. Magnitude and trend of the associations across different SES groups are similar to those reported in the literature [1,17,18]. Stronger associations of SES differences in diabetes for women have been reported before as well [30]. With the selected SES indicators different but related aspects of social inequalities are measured representing different stages in the life course [18,31]. As associations for all of the explored SES indicators were found, our results give supporting evidence that health inequalities in diabetes are affected by diverse social conditions during different stages in life [18,32]. As expected, considering the given sample size and the relatively small number of diabetes cases in the study population, only 5 of the 11 selected diabetes-related SNPs (5 of the 8 genetic loci) were replicated with nominal statistically significant results for their association with diabetes status. However, all SNP alleles showed directionally consistent effects when compared with those reported in the literature [19-21]. The main finding of the study is the lack of evidence for the contribution of 11 selected diabetes-related SNPs representing 8 genetic loci to the observed health inequalities in diabetes. There were no statistically significant associations between the individual SNPs and SES indicators after conservatively controlling for multiple testing by the Bonferroni method. Even with an uncorrected level of significance (α = 0.05) the number of estimators with p < α does not exceed the number expected by chance. In general, no clear inverse trend of the calculated ORs could be found across the different SES groups. There may be a few exceptions for markers related to FTO (for paternal occupation), PPARG, CDKAL1 and CDKN2A/2B (for education). As the differences between the respective ORs are small and statistically significant results were missing, they have to be interpreted as random trends. Furthermore, we observed many ORs < 1.0 which we would not expect if the risk alleles of the selected SNPs generally have an impact on the observed health inequalities in diabetes. In addition, the highest ORs – which are only of small to modest magnitude – were not exclusively present for the lowest compared with the highest SES group. The results for using the genetic risk score in the analyses support the observations for the individual SNPs: The sum of selected diabetes risk alleles is not increasing with a decreasing in SES. To our knowledge, this is the first study investigating social inequalities in diabetes and simultaneously exploring the impact of selected SNPs robustly associated with diabetes. There are just a few studies that have investigated supposed differences in risk allele frequencies to estimate their contribution to health inequalities with varying results [33,34]. Only Holzapfel et al. [34] analyzed the relationship between SES, body mass index (BMI) and the SNP rs9935401 within FTO, which is also associated with diabetes through its effect on BMI. They reported no association with education and income for rs9935401. This is in line with our observations for the FTO marker rs8050136, which is strongly correlated to rs9935401 (r  = 1.0) within the HapMap CEU population. Our study suggests that there is no contribution of diabetes-related SNPs to health inequalities in terms of differences in risk allele frequencies between SES groups. The question remains, how genetic factors could adequately be integrated in explanations of health inequalities. One possible approach is offered by the life course perspective [35-37], which describes the interplay of biological, environmental and social factors and their impact on health over the life course. Thus, the life course perspective is not tied to the assumption of a single causal direction as described by, e.g., the hypothesis of direct health selection. Following this approach, a more plausible picture of genetic risk factors interacting with environmental and social factors can be drawn to give consideration to the complex chain of risks that produces health inequalities. The following limitations of the study need to be considered: First, due to the given sample size the statistical power to confirm the reported genetic associations with diabetes and to detect associations between the SNPs and the SES indicators – especially in the analyses with categorized SES indicators – is limited. To address this limitation and to increase the detection power we also used a genetic risk score for our analyses. Second, over 66 genomic loci related to diabetes are already described which account for approximately 6% of variance in diabetes susceptibility suggesting that there still may be some unexplained genetic variance [38]. Thus, the present investigation of the relationship between diabetes-related genomic loci and SES indicators is far from being comprehensive. Given that the more recently discovered loci yield smaller effects on diabetes than the SNPs explored here, our analysis should be regarded as a first step to address the relationship of diabetes-related genomic loci with SES indicators. Third, as we do not have information on diabetes status of earlier life stages it was not possible to check for the causal direction of the association between the SES indicators and diabetes. However, especially for education and paternal occupation reverse causation is unlikely as the former is a stable indicator of socioeconomic status across the life course and the latter of the participants’ childhood. For income, reverse causation cannot be ruled out. Fourth, the validity of the SES indicators is restricted. For education and income this is due to their age dependency. The distribution of educational degrees varies by age groups with the higher groups showing lower variance and income generally declines in relation to retirement. Therefore, these indicators of SES may be more valid in younger age groups.

Conclusions

Despite the mentioned limitations, our study confirms social inequalities in diabetes for different indicators of SES and provides no evidence that a selection of common genetic variants with the largest reported diabetes effects plays a role in the observed health inequalities. However, replication of our results, assessment of larger genetic marker panels and empirical analyses for other types of diseases are needed to further challenge the claims that differences in genetic predisposition could explain social inequalities in health.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

KHJ, RE, SM and ND contributed to the conception, study design and data acquisition. BS conducted statistical analyses and contributed to the study design and interpretation of results. AS and SP contributed to statistical analyses and interpretation of results. MMN and PH carried out SNP genotyping. All authors contributed to manuscript preparation, and read and approved the final manuscript.

Pre-publication history

The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2458/14/609/prepub
  30 in total

1.  Health selection: the role of inter- and intra-generational mobility on social inequalities in health.

Authors:  Orly Manor; Sharon Matthews; Chris Power
Journal:  Soc Sci Med       Date:  2003-12       Impact factor: 4.634

Review 2.  Life course epidemiology.

Authors:  D Kuh; Y Ben-Shlomo; J Lynch; J Hallqvist; C Power
Journal:  J Epidemiol Community Health       Date:  2003-10       Impact factor: 3.710

Review 3.  Genetics and social class.

Authors:  N A Holtzman
Journal:  J Epidemiol Community Health       Date:  2002-07       Impact factor: 3.710

Review 4.  Genetics and health inequalities: hypotheses and controversies.

Authors:  Johan P Mackenbach
Journal:  J Epidemiol Community Health       Date:  2005-04       Impact factor: 3.710

5.  Health inequalities in the life course perspective.

Authors:  M E Wadsworth
Journal:  Soc Sci Med       Date:  1997-03       Impact factor: 4.634

6.  Socioeconomic differences in the prevalence of common chronic diseases: an overview of eight European countries.

Authors:  J A A Dalstra; A E Kunst; C Borrell; E Breeze; E Cambois; G Costa; J J M Geurts; E Lahelma; H Van Oyen; N K Rasmussen; E Regidor; T Spadea; J P Mackenbach
Journal:  Int J Epidemiol       Date:  2005-02-28       Impact factor: 7.196

7.  Baseline recruitment and analyses of nonresponse of the Heinz Nixdorf Recall Study: identifiability of phone numbers as the major determinant of response.

Authors:  A Stang; S Moebus; N Dragano; E M Beck; S Möhlenkamp; A Schmermund; J Siegrist; R Erbel; K H Jöckel
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

8.  Effect of environmental and genetic factors on education-associated disparities in weight and weight gain: a study of Finnish adult twins.

Authors:  Karri Silventoinen; Sirpa Sarlio-Lähteenkorva; Markku Koskenvuo; Eero Lahelma; Jaakko Kaprio
Journal:  Am J Clin Nutr       Date:  2004-10       Impact factor: 7.045

9.  Gender-related differences in the association between socioeconomic status and self-reported diabetes.

Authors:  Mei Tang; Yue Chen; Daniel Krewski
Journal:  Int J Epidemiol       Date:  2003-06       Impact factor: 7.196

10.  Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes.

Authors:  Andrew P Morris; Benjamin F Voight; Tanya M Teslovich; Teresa Ferreira; Ayellet V Segrè; Valgerdur Steinthorsdottir; Rona J Strawbridge; Hassan Khan; Harald Grallert; Anubha Mahajan; Inga Prokopenko; Hyun Min Kang; Christian Dina; Tonu Esko; Ross M Fraser; Stavroula Kanoni; Ashish Kumar; Vasiliki Lagou; Claudia Langenberg; Jian'an Luan; Cecilia M Lindgren; Martina Müller-Nurasyid; Sonali Pechlivanis; N William Rayner; Laura J Scott; Steven Wiltshire; Loic Yengo; Leena Kinnunen; Elizabeth J Rossin; Soumya Raychaudhuri; Andrew D Johnson; Antigone S Dimas; Ruth J F Loos; Sailaja Vedantam; Han Chen; Jose C Florez; Caroline Fox; Ching-Ti Liu; Denis Rybin; David J Couper; Wen Hong L Kao; Man Li; Marilyn C Cornelis; Peter Kraft; Qi Sun; Rob M van Dam; Heather M Stringham; Peter S Chines; Krista Fischer; Pierre Fontanillas; Oddgeir L Holmen; Sarah E Hunt; Anne U Jackson; Augustine Kong; Robert Lawrence; Julia Meyer; John R B Perry; Carl G P Platou; Simon Potter; Emil Rehnberg; Neil Robertson; Suthesh Sivapalaratnam; Alena Stančáková; Kathleen Stirrups; Gudmar Thorleifsson; Emmi Tikkanen; Andrew R Wood; Peter Almgren; Mustafa Atalay; Rafn Benediktsson; Lori L Bonnycastle; Noël Burtt; Jason Carey; Guillaume Charpentier; Andrew T Crenshaw; Alex S F Doney; Mozhgan Dorkhan; Sarah Edkins; Valur Emilsson; Elodie Eury; Tom Forsen; Karl Gertow; Bruna Gigante; George B Grant; Christopher J Groves; Candace Guiducci; Christian Herder; Astradur B Hreidarsson; Jennie Hui; Alan James; Anna Jonsson; Wolfgang Rathmann; Norman Klopp; Jasmina Kravic; Kaarel Krjutškov; Cordelia Langford; Karin Leander; Eero Lindholm; Stéphane Lobbens; Satu Männistö; Ghazala Mirza; Thomas W Mühleisen; Bill Musk; Melissa Parkin; Loukianos Rallidis; Jouko Saramies; Bengt Sennblad; Sonia Shah; Gunnar Sigurðsson; Angela Silveira; Gerald Steinbach; Barbara Thorand; Joseph Trakalo; Fabrizio Veglia; Roman Wennauer; Wendy Winckler; Delilah Zabaneh; Harry Campbell; Cornelia van Duijn; Andre G Uitterlinden; Albert Hofman; Eric Sijbrands; Goncalo R Abecasis; Katharine R Owen; Eleftheria Zeggini; Mieke D Trip; Nita G Forouhi; Ann-Christine Syvänen; Johan G Eriksson; Leena Peltonen; Markus M Nöthen; Beverley Balkau; Colin N A Palmer; Valeriya Lyssenko; Tiinamaija Tuomi; Bo Isomaa; David J Hunter; Lu Qi; Alan R Shuldiner; Michael Roden; Ines Barroso; Tom Wilsgaard; John Beilby; Kees Hovingh; Jackie F Price; James F Wilson; Rainer Rauramaa; Timo A Lakka; Lars Lind; George Dedoussis; Inger Njølstad; Nancy L Pedersen; Kay-Tee Khaw; Nicholas J Wareham; Sirkka M Keinanen-Kiukaanniemi; Timo E Saaristo; Eeva Korpi-Hyövälti; Juha Saltevo; Markku Laakso; Johanna Kuusisto; Andres Metspalu; Francis S Collins; Karen L Mohlke; Richard N Bergman; Jaakko Tuomilehto; Bernhard O Boehm; Christian Gieger; Kristian Hveem; Stephane Cauchi; Philippe Froguel; Damiano Baldassarre; Elena Tremoli; Steve E Humphries; Danish Saleheen; John Danesh; Erik Ingelsson; Samuli Ripatti; Veikko Salomaa; Raimund Erbel; Karl-Heinz Jöckel; Susanne Moebus; Annette Peters; Thomas Illig; Ulf de Faire; Anders Hamsten; Andrew D Morris; Peter J Donnelly; Timothy M Frayling; Andrew T Hattersley; Eric Boerwinkle; Olle Melander; Sekar Kathiresan; Peter M Nilsson; Panos Deloukas; Unnur Thorsteinsdottir; Leif C Groop; Kari Stefansson; Frank Hu; James S Pankow; Josée Dupuis; James B Meigs; David Altshuler; Michael Boehnke; Mark I McCarthy
Journal:  Nat Genet       Date:  2012-08-12       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.